STOCKS TELEGRAPH

Tag: CRVS

  • Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    US stock exchanges fell on Monday in line with the overall decline in risk sentiment in global markets, according to trading data.

    The Dow Jones Industrial Average (DJIA) fell by 0.33% to 31391.89 points, the NASDAQ high-tech index – by 0.86% to 13756.78 points, the broad market S&P 500 index – by 0.47%, up to 3887.8 points.

    Monday traders are risk averse. Their attention turned to the possible consequences of the economic recovery after the pandemic. In particular, investors are concerned that the US $1.9 trillion stimulus package will lead to increased economic activity and a surge in inflation, which in turn could prompt the Fed to tighten monetary policy.

    At preliminary trades, the pressure on the share price was also exerted by the growth of the yield on US government bonds to the maximum since February last year, which contributed to the strengthening of the dollar. However, the yield on government bonds has already moved to a correctional decline. The dollar is also slightly declining.

    Meanwhile, the shares of the American concern Boeing are losing 1.8% after the company recommended to suspend flights of 777 liners with a Pratt & Whitney PW4000-112 engine amid an emergency with an engine in Colorado.

    Today Top Movers‎

    ReTo Eco-Solutions Inc. (NASDAQ: RETO) shares are trading up 36.75% at $3.2 at the time of writing.

    Vascular Biogenics Ltd (VBLT) jumper over 58.30% at $3.53 in pre-market trading today after declaring results of the independent Data Safety Monitoring Committee pre-planned review of the ongoing OVAL Phase 3 registration enabling study of VB-111 in recurrent ovarian cancer. ‎

    TFF Pharmaceuticals Inc. (TFFP) stock soared 10.2% to $17.5 in the pre-market ‎trading.

    Celsion Corporation (CLSN), a biotechnology company, dropped about -22.42% at $2.18 in pre-market trading Tuesday after receiving FDA fast track designation for GEN-1 in Advanced Ovarian Cancer.‎ ‎

    Top Upgrades & Downgrades

    KeyBanc turned bullish on iQIYI Inc. (IQ), upgrading the stock to “Overweight” and assigning a $30.0 price target, representing a potential upside of 25.63% from Monday’s close. 

    TimkenSteel Corporation (TMST) has won the favor of KeyBanc’s equity research team. The firm upgraded the shares from Sector Weight to Overweight and moved their price target to $10.0, suggesting 58.98% additional upside for the stock. 

    Vertex Pharmaceuticals Incorporated (VRTX) received an upgrade from analysts at Baird, who also set their one-year price target on the stock to $252. They changed their rating on VRTX to Outperform from Neutral in a recently issued research note.

    Earlier Tuesday Jefferies reduced its rating on GasLog Ltd. (GLOG) stock to Hold from Buy and assigned the price target to $5.8. 

    Evercore ISI analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Principal Financial Group Inc. (PFG) has been changed to In Line from Outperform and the new price target is set at $63. 

    Analysts at Societe Generale downgraded DISH Network Corporation (DISH)’s stock to Sell from Hold Tuesday.

    Latest Insider Activity

    Pinterest Inc. (PINS) Director Levine Jeremy S. announced the sale of shares taking place on Feb 19 at $86.47 for some 150,000 shares. The total came to more than $12.97 million. 

    Coeur Mining Inc. (CDE) SVP, Exploration Rasmussen Hans John sold on Feb 22 a total 309,185 shares at $8.91 on average. The insider’s sale generated proceeds of almost $32967. 

    SLM Corporation (SLM) Director Franke Mary Carter Warren declared the purchase of shares taking place on Feb 17 at $15.03 for some 7,000 shares. The transaction amount was around $0.11 million. 

    Corvus Pharmaceuticals Inc. (CRVS) President and CEO MILLER RICHARD A MD bought on Feb 17 a total 1,278,515 shares at $3.50 on average. The purchase cost the insider an estimated $350,000.

    Important Earnings

    Top US earnings releases scheduled for today include Macy’s Inc. (NYSE: M). It will announce its Jan 2021 financial results. The company is expected to report earnings of $0.12 per share from revenues of $6.5B in the three-month period. 

    Analysts expect Square, Inc. (SQ) to report a net income (adjusted) of $0.24 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $3.09B. 

    B2Gold Corp. (BTG), due to announce earnings after the market closes today, is expected to report earnings of $0.01 per share from revenues of $207.75M recently concluded three-month period.

  • Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    On February 9, American stock exchanges were trading in narrow ranges. The S&P 500 index fell 0.11% to 3911 points, the Dow Jones lost a symbolic 0.03%, the NASDAQ added 0.14%. The upward movement has stalled due to the lack of new drivers. The energy sector corrected 1.52% after the rally the day before. The strongest was the real estate sector, which added 0.47%.

    Company news

    Game developer Take-Two Interactive Software (TTWO: -6.1%) beat expectations, but stock corrected due to lack of clarity on its fiscal 2022 release schedule.

    Shopify e-commerce platform (SHOP: + 6.5%) announced the integration of the Shop Pay payment method on Facebook and Instagram.

    Electronic Arts (EA: + 2.6%) buys mobile game developer Glu Mobile (GLUU: + 35%) for cash. The deal will amount to $ 2.1 billion.

    Today, world stock exchanges are showing mostly positive dynamics. The news background is calm. The Biden administration said on Monday that the fiscal stimulus package will likely be passed through a simplified voting procedure requiring only a Democratic majority for approval. However, this was already a highly anticipated scenario, since President Biden, the majority of Democrats, and Treasury Secretary Janet Yellen insist on a significant amount of the anti-crisis program. This positive factor continues to support buyers, but to a large extent it has already been taken into account in the quotes. The only question that remains is what changes the bill will undergo in order to be approved by the centrist democrats.

    The Freedom Finance Sentiment Index climbed to 57 out of 100. The index reflects market participants’ hope for a global economic recovery in 2021. Concerns about the negative impact of the coronavirus pandemic are gradually diminishing with the approach of mass vaccinations.

    Technical picture

    Technically, the S&P 500 is still in a medium-term uptrend. The trading session the day before did not change the overall picture. The upper limit of the trend at 3920 is still a significant obstacle. After the S&P 500 rallied 4% last week, short-term consolidation is likely.

    Today Top Movers

    Sundial Growers Inc (SNDL), a drug manufacturer company, soared about 18.18% ‎at $1.95 in pre-market ‎trading Wednesday.‎‎ 

    ‎Tilray Inc (TLRY) share price jumped 24.53% to $52.74 during the early morning ‎trading session on ‎Wednesday after declaring an agreement with British company Grow Pharma, to export medical marijuana to the U.K. ‎‎ 

    ‎Gamida Cell Ltd (GMDA) stock ascended 55.01% at $15.33 in the pre-‎market trading today.‎‎ The company recently revealed the results of Phase 3 clinical study of omidubicel. 

    ‎Genfit (GNFT) gained over 29.30% at $6.84 in pre-market ‎trading on Wednesday following the publication of positive results from the phase 2 clinical trial evaluating elafibranor in patients with PBC in the Journal of Hepatology.‎

    Top Upgrades & Downgrades

    SVB Leerink turned bullish on Deciphera Pharmaceuticals Inc. (DCPH), upgrading the stock to “Outperform” and assigning a $70.0 price target, representing a potential upside of 44.87% from Tuesday’s close.

    Model N Inc. (MODN) has won the favor of JP Morgan’s equity research team. The firm upgraded the shares from Underweight to Neutral and moved their price target to $40.

    The Hain Celestial Group Inc. (HAIN) received an upgrade from analysts at Piper Sandler, who also set their one-year price target on the stock to $50.0. They changed their rating on HAIN to Overweight from Neutral in a recently issued research note.

    Earlier Wednesday Raymond James reduced its rating on Leggett & Platt Incorporated (LEG) stock to Outperform from Strong Buy.

    JPMorgan analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Change Healthcare Inc. (CHNG) has been changed to Neutral from Overweight and the new price target is set at $25.75.

    Analysts at Mizuho downgraded Corvus Pharmaceuticals Inc. (CRVS)’s stock to Neutral from Buy Wednesday.

    Latest Insider Activity

    Tyme Technologies Inc. (TYME) 10% Owner Demurjian Michael announced the sale of shares taking place on Feb 08 at $2.45 for some 20,000 shares. The total came to more than $49000.

    Square Inc. (SQ) Chief Financial Officer Ahuja Amrita sold on Feb 05 a total of 149,866 shares at $240.45 on average. The insider’s sale generated proceeds of almost $1.01 million.

    International Business Machines Corporation (IBM) Director HOWARD MICHELLE J declared the purchase of shares taking place on Feb 08 at $123.30 for some 64 shares. The transaction amount was around $7891.

    UnitedHealth Group Incorporated (UNH) Director FLYNN TIMOTHY PATRICK bought on Feb 05 a total of 6,972 shares at $332.68 on average. The purchase cost the insider an estimated $499,026.

    Important Earnings


    Top US earnings releases scheduled for today include Veru Inc. (NASDAQ: VERU). It will announce its Dec 2020 financial results. The company is expected to report earnings of -$0.06 per share from revenues of $10.57M in the three-month period.

    Analysts expect General Motors Company (NYSE: GM) to report a net income (adjusted) of $1.64 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $36.12B.

    Uber Technologies Inc. (UBER), due to announce earnings after the market closes today, is expected to report earnings of -$0.55 per share from revenues of $3.58B recently concluded three-month period.

  • 3 High Potential Stock to Watch Today: Biotechs Lead the Way

    MyoKardia Inc [NASDAQ: MYOK]

    In a bid to expand its portfolio of heart drugs, Bristol-Myers Squibb Co. Has agreed with MyoKardia Inc to purchase the company for $13.1 billion. In the agreement, Bristol-Myers is set to pay $225 per share which is about 61% premium over the company’s Friday’s closing stock price. MyoKardia’s stock price had risen 59% in its premarket trading.  Following this purchase, Bristol-Myers will now control MyoKardia’s leading product Mavacamten.

    This experimental drug treats obstructive hypertrophic cardiomyopathy. This acquisition will have expanded Bristol-Myers’ scope of heart drugs from those focussing only on oncology, an area where the industry has focussed on for quite a while now. According to the statement issued regarding this deal, Bristol-Myers will issue an application for the approval of Mavacamten during the first quarter of 2021.

    The company plans to research more on the uses of this drug and manufacture other additional experimental compounds that they will get from MyoKardia. Hypertrophic cardiomyopathy is a heart condition in which heart muscles develop abnormal thickness preventing the heart from pumping blood effectively. The condition affects about one in 500 people.

    Kosmos Energy Ltd [NYSE: KOS]  

    Kosmos Energy, a deepwater independent gas and oil exploration and production company announced today that it has shut down its facility at the Gulf of Mexico with Trafigura Trading LLC and Beal Bank USA.  In a move set to strengthen the corporation’s liquidity position, it has restructured its facility at the Gulf of Mexico into a five-year $200 million loan term that will be backed by the company’s assets at the same Gulf.

    Another $50 million advanced from Trafigura signed in June has been rolled into the facility with backing from CSG Investments; Inc. Beal Bank will provide the remaining $150 million. With a 6% interest rate, the facility has increased its borrowing capacity by $50 million, extended its repayment term by five years, and secured a feature to expand the facility by up to $300 million.

    Neal Shah, the Chief Financial Officer said in a statement that the closing of this facility has enhanced the company’s liquidity position, given it access to low-cost and flexible financing as well as free cash generated low-cost production assets. He expects the company’s balance sheet to strengthen significantly as of 2021.

    Corvus Pharmaceuticals Inc [NASDAQ: CRVS]

    Corvus share price saw a sudden spike after the company announced that its small phase 1 early-stage clinical trial could produce antibodies and T-cells among some Covid-19 patients. The share price rose by 39.1% in premarket trading on Monday after this announcement.

    The clinical trial, open-label, Phase 1 study has already administered three doses in 15 test-patients and hopes to expand its scope to about 30 patients that exhibit mild to moderate symptoms of the disease.  In a preprint issued in September, the company had shown the results for the two of the doses administered in 10 patients. This publication has not been peer-reviewed.

    Corvus plans to release the full results from the first phase at the end of this year.  Its stock is still 25.2% down as of this year with the S&P 500 gaining about 3.6%.